Second-line treatment with sacituzumab govitecan-hziy led to responses in patients with extensive-stage small cell lung cancer, according to results from the phase 2 TROPiCS-03 trial.
Research highlights industry and regulatory perspectives on improving diversity in clinical trials medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The "Cancer Therapies: Global Strategic Business Report" report has been added to ResearchAndMarkets.com s offering. Global Cancer Therapies.
Hepatocellular carcinoma (HCC), the most common type of liver cancer, is already the third leading cause of cancer-related deaths worldwide and cases are on the rise in both the United States and around the world
Liver Cancer Manipulates Internal Clock to Spread: Study miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.